Eosinophil trafficking in asthma

Clinical Medicine

Volumn 1, Issue 3, 2001, Pages 214-218

  Wardlaw, Andrew J ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; BLOOD; CELL MOTION; DRUG EFFECT; EOSINOPHIL; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ASTHMA; CELL MOVEMENT; EOSINOPHILS; HUMANS;

EID: 0035348498     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.1-3-214     Document Type: Article

References (27)

1. Wardlaw AJ, Moqbel R, Kay AB. Eosinophils: biology and role in disease. Review. Adv Immunol 1995;60:151-266.
2. Wardlaw AJ. Molecular basis for selective eosinophil trafficking in asthma. A multi-step paradigm. J Allergy Clin Immunol 1999;104: 917-26
3. Sehmi R, Cromwell O, Taylor GW, Kay AB. Identification of guinea pig eosinophil chemotactic factor of anaphylaxis as leukotriene B4 and 8(S),15(S)-dihydroxy-5,9,11,13(Z,E,Z,E)-eicosatetraenoic acid. J Immunol 1991;147:2276-83.
4. Wardlaw AJ, Moqbel R, Cromwell O, Kay AB. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 1986;78:1701-6.
5. Wardlaw AJ, Brightling CE, Green R, Woltmann G, Pavord ID. Eosinophils in asthma and allergic disease. In: Kay AB (ed). Allergic diseases. London: British Council, 2001 (in press).
6. Denburg JA. The origins of basophils and eosinophils in allergic inflammation. J Allergy Clin Immunol 1998;102:S74-6.
7. Robinson DS, Damia R, Zeibecoglou K, Molet S, et al. CD34(+)/interleukin-5R alpha messenger RNA+ cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors. Am J Respir Cell Mol Biol 1999;20:9-13.
8. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183:195-201.
9. Palframan RT, Collins PD, Severs NJ, Rothery S, et al. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J Exp Med 1998;188:1621-32.
10. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Review. Cell 1991;67:1033-6.
11. Symon FA, Lawrence MB, Williamson ML, Walsh GM, et al. Functional and structural characterization of the eosinophil P-selectin ligand. J Immunol 1996;157:1711-9.
12. Edwards BS, Curry MS, Tsuji H, Brown D, et al. Expression of P-selectin at low site density promotes selective attachment of eosinophils over neutrophils. J Immunol 2000;165:404-10.
13. Woltmann G, McNulty CA, Dewson G, Symon FA, Wardlaw AJ. Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow. Blood 2000;95:3146-52.
14. Patel KD. Eosinophil tethering to interleukin-4-activated endothelial cells requires both P-selectin and vascular cell adhesion molecule-1. Blood 1998;92:3904-11.
15. Symon FA, Walsh GM, Watson SR, Wardlaw AJ. Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent. J Exp Med 1994;180: 371-6.
16. Hamilos DL, Thawley SE, Kramper MA, Kamil A, Hamid QA. Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease. J Allergy Clin Immunol 1999;103:79-87.
17. Broide DH, Sullivan S, Gifford T, Sriramarao P. Inhibition of pulmonary eosinophilia in P-selectin- and ICAM-1-deficient mice. Am J Respir Cell Mol Biol 1998;18:218-25.
18. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Review. Science 1996;272:60-6.
19. Teran LM. CCL chemokines and asthma. Review. Immunol Today 2000; 21:235-42.
20. Rothenberg ME, Zimmermann N, Mishra A, Brandt E, et al. Chemokines and chemokine receptors: their role in allergic airway disease. Review. J Clin Immunol 1999;19:250-65.
21. Li L, Xia Y, Nguyen A, Lai YH, et al. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 1999;162:2477-87.
22. Adachi T, Alam R. The mechanism of IL-5 signal transduction. Review. Am J Physiol 1998;275:C623-33.
23. Simon HU (editorial). Eosinophil apoptosis in allergic diseases - an emerging new issue. Clin Exp Allergy 1998;28:1321-4.
24. Simon HU, Yousefi S, Schranz C, Schapowal A, et al. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:3902-8.
25. Druilhe A, Wallaert B, Tsicopoulos A, Lapa e Silva JR, et al. Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics. Am J Respir Cell Mol Biol 1998;19:747-57.
26. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-61.
27. Akimoto T, Numata F, Tamura M, Takata Y, et al. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice. J Exp Med 1998;187:1537-42.